Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Charlotte Medin"'
Autor:
Ming Pei, Rute Aguiar, Agneta A. Pagels, Olof Heimbürger, Peter Stenvinkel, Peter Bárány, Charlotte Medin, Stefan H. Jacobson, Britta Hylander, Bengt Lindholm, Abdul Rashid Qureshi
Publikováno v:
BMC Nephrology, Vol 20, Iss 1, Pp 1-10 (2019)
Abstract Background Health-related quality of life (HRQoL) is an important component of patient-centered outcomes and a useful parameter for monitoring quality of care. We assessed HRQoL, its determinants, and associations with mortality in patients
Externí odkaz:
https://doaj.org/article/5067c26462a54b8ba1a6a72f7135c35c
Autor:
Charlotte Medin, Sunna Snaedal-Jonsdottir, Maarit Korkeila, Samiha Benedek, Marie Hilderman, Annette Bruchfeld
Publikováno v:
Nephrology Dialysis Transplantation. 29:851-856
Background. Minimal change nephropathy or disease (MCD) accounts for 10–15% of cases of the nephrotic syndrome in adults with frequent relapses occurring in up to 25% of cases. The drug of choice is glucocorticoids (GCs), but GC-dependence is seen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::447c533467232d06d91358c6eab69d9f
https://doi.org/10.1093/ndt/gft312
https://doi.org/10.1093/ndt/gft312
Publikováno v:
Nephrology Research & Reviews. 2:8-11
Minimal-change nephropathy (MCN) accounts for 10–15% of cases of the nephrotic syndrome in adults. Frequent relapses occur in 10–25% of cases and steroid dependence is seen in 25–30%. Rituximab is a chimeric mono-clonal antibody directed agains
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::afb306b951019745e1ea9e664708c1f4
https://doi.org/10.4081/nr.2010.e2
https://doi.org/10.4081/nr.2010.e2
Autor:
Colin C. Geddes, Ernst H. Scheuermann, Charlotte Medin, Francesco Locatelli, Sandor Sonkodi, Magdalena Krajewska, J. L. Poignet, Guillermina Barril, Patrick Goubau, Michel Jadoul
Publikováno v:
Nephrology Dialysis Transplantation. 19:904-909
BACKGROUND: The high prevalence of anti-hepatitis C virus (HCV) antibodies in HD patients has been known since the early 1990s but its evolution over the last decade is poorly documented. METHODS: All chronic HD patients from 15 Belgian units were te
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::782a5b0e0af0ad252c80b2489c9562bd
https://doi.org/10.1093/ndt/gfh012
https://doi.org/10.1093/ndt/gfh012
Autor:
Ingegerd Odar-Cederlöf, Per Diener, Charlotte Medin, Lisbeth Barkholt, Lars Ståhle, Jan-Olof Svensson, Anders Helldén, Juliette Säwe
Publikováno v:
Nephrology Dialysis Transplantation. 18:1135-1141
Background. Acyclovir (ACV) has been used for over two decades to treat herpes virus infections. Serious neurological adverse side effects have occurred during ACV treatment in patients with renal failure, but the cause of the symptoms remains unknow
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0dc0f87dd7a8928a34ce4558e224844
https://doi.org/10.1093/ndt/gfg119
https://doi.org/10.1093/ndt/gfg119
Publikováno v:
Nephrology Dialysis Transplantation. 15:701-704
Introduction Survival of transplanted patients is generally much better than for those on dialysis. This comparison is, however, incorrect, as in order to be accepted for renal transplantation the patient has to be in a relatively good condition and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::875d203e4357fdb1093538e27ec28496
https://doi.org/10.1093/ndt/15.5.701
https://doi.org/10.1093/ndt/15.5.701
Publikováno v:
Health and Quality of Life Outcomes
Health and Quality of Life Outcomes, Vol 10, Iss 1, p 71 (2012)
Health and Quality of Life Outcomes, Vol 10, Iss 1, p 71 (2012)
Objectives To evaluate health-related quality of life (HRQoL) in patients in different stages of chronic kidney disease (CKD) up to initiation of dialysis treatment and to explore possible correlating and influencing factors. Methods Cross-sectional
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5462964c2548401ab84662eb1109b12a
https://pubmed.ncbi.nlm.nih.gov/22710013
https://pubmed.ncbi.nlm.nih.gov/22710013
Publikováno v:
Nephron. 65:40-45
The prevalence and incidence of hepatitis C virus (HCV) infections were studied in 236 dialysis patients and related to clinical data at two hospitals in Stockholm, Sweden. Patients were followed during 12 months and tested by 1st- and 2nd-generation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e0bd674bb29edeec5107342e173442d
https://doi.org/10.1159/000187438
https://doi.org/10.1159/000187438
Autor:
Anders, Helldén, Ulf, Bergman, Richard, Dwyer, Charlotte, Medin, Hadi, Molanaei, Lars, Ståhle, Pia, Thylén, Ingegerd, Odar-Cederlöf
Publikováno v:
Lakartidningen. 104(24-25)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fd8f5ea762916cae4b559b85f44cd954
https://pubmed.ncbi.nlm.nih.gov/17674672
https://pubmed.ncbi.nlm.nih.gov/17674672
Publikováno v:
Journal of medical virology. 43(4)
Three cases of simultaneous seroconversion to hepatitis C virus (HCV) in a hemodialysis unit initiated the investigation of the viral strains of 14 seropositive patients in the unit by nucleotide sequencing. The results showed that five patients had
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40e316939e1adfef1dea8163f06063d1
https://pubmed.ncbi.nlm.nih.gov/7545963
https://pubmed.ncbi.nlm.nih.gov/7545963